Release Date: 06/04/11 16:53 Summary: Director and Chief Executive Resignation Price Sensitive: No Download Document 85.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%